| Comparison of common methods for cell transfection and rAAV2 purification with commercially available options |
|
2024 |
| Double thermal cauterization of the limbal plexus as an inducible model of glaucoma in rats. |
|
2023 |
| Comparison of rat retinal ganglion cell transduction with different amounts of rAAV vector. |
|
2022 |
| Construction of dead-Cas9 machinery for activation of endogeous neuroprotective transcription factor MAX in vitro |
|
2022 |
| Comparison of rat retinal ganglion cells transduction using different human mini-promoters compatible with rAAV |
|
2022 |
| Increased transgene expression in rat retinal ganglion cells by using human mini-promoters compatible with rAAV |
|
2021 |
| Increased transgene expression in rat retinal ganglion cells by using human mini-promoters compartible with rAAV |
|
2020 |
| Análise de mini-promotores para expressão em células ganglionares da retina de ratos adultos |
|
2019 |
| Análise de mini-promotores para expressão em células ganglionares da retina de ratos adultos |
|
2019 |
| Modulation of gene transduction by rAAV2 in the rat retina after intravitreal injection. |
|
2018 |
| Neuroprotection by overexpression of the transcription factor Max in experimental glaucoma |
|
2018 |
| Gene and cell therapy: combining two approaches to promote neuroprotection and neuroregeneration in a model of optic nerve injury |
|
2017 |
| Análise de mini-promotores para expressão em células ganglionares da retina de ratos adultos. |
|
2017 |
| Impacto da modulação de barreiras intra e extracelulares sobre a eficiência de transdução gênica mediada pelo vetor viral rAAV2 na retina de ratos após injeção intravítrea. |
|
2017 |
| Neuroprotective effect of gene therapy in rodent models of glaucoma using rAAV2-hMAX |
|
2017 |
| Thermal cauterization of the limbal plexus as a new inducible model of glaucoma in rats. |
|
2017 |
| Gene and cell therapy: combining two approaches to promote neuroprotection and neuroregeneration in a model of optic nerve injury |
|
2016 |
| Evaluations of olfactory unsheathing glia gene reprogramming by recombinant adeno-associated viral vector type 2 in vitro and in vivo |
|
2015 |
| CHIP, a carboxy terminus HSP-70 interacting protein, prevents cell death induced by endoplasmic reticulum stress in the central nervous system |
|
2014 |
| GENE AND CELL THERAPY: TWO APPROACHS TO PROMOTE NEUROPROTECTION AND NEUROREGENERATION IN A MODEL OF CNS INJURY |
|
2014 |
| Co-chaperone CHIP attenuates neuronal death upon ER stress |
|
2013 |
| Supplementation of Rds in rds/+ Mice Model for Gene Therapy Using Hirbp Promoter In an AAV Vector |
|
2011 |
| Neuroprotective Gene Expression with AAV8 for Oxygen-Glycose Deprivation in Organotypic Hippocampal Culture: A Model of Ischemic Stroke |
|
2011 |
| Suppression of rds Expression by siRNA and Gene Replacement Strategies for Gene Therapy Using AAV Vector |
|
2010 |
| Tyrosine Mutations in the Capsid of AAV Vectors Alters Transduction Properties in the Retina |
|
2010 |
| Suppression of rds expression by siRNA and gene replacement strategies for gene therapy using AAV vector |
|
2009 |
| Highly Efficient Subretinal Gene Transfer in the Mouse by AAV Vectors with Capsid Tyrosine Mutations |
|
2009 |
| Dose- Dependent Humoral Immune Responses to Intravitreal Delivery of AAV Vectors and Strategies to Circumvent |
|
2009 |
| Transcription Factor Max Is Neuroprotective for Retinal Ganglion Cells: On the Road to Gene Therapy for Glaucoma |
|
2008 |
| Improving Retinal Ganglion Cell Transduction by Using scAAV Type 8 or Type 9 Vectors Containing Capsid Mutations |
|
2008 |
| Transduction and Tropism of an Abbreviated Form of CMV?Chicken ß?Actin Promoter (CBA) With AAV in Mouse Retina |
|
2006 |
| Self?Complementary AAV Vectors Promote Fast and Efficient Transduction of Mouse Retina |
|
2006 |
| Neuroprotection by gene transfer of transcription factor Max |
|
2005 |
| Does Adeno-associated virus (AAV-2) utilization in the pulmonary genetics therapy cause damages in the pulmonary function? |
|
2005 |
| A utilização do adenovírus-associado (AAV-2) na terapia gênica pulmonar causa danos na função pulmonar? |
|
2005 |
| Modulation of the transcription factor Max expression in rat retinal ganglion cells, using a recombinant adeno-associated viral vector |
|
2004 |
| Nuclear exclusion of the transcription factor Max: a novel event associated with retinal ganglion cell death |
|
2003 |
| Nuclear exclusion of the transcription factor Max during programmed cell death |
|
2002 |
| Exclusão nuclear do fator de transcrição Max durante a morte celular programada |
|
2002 |
| Nuclear exclusion of the transcription factorsc-Myc and Max during programmed cell death |
|
2001 |
| Nuclear exclusion of the transcription factors c-Myc and Max during programmed cell death |
|
2001 |
| Nuclear exclusion of transcription factors and Ref-1 during programmed cell death |
|
2000 |
| Associative control of apoptosis in the developing retina: evidence that Ref-1 is an anti-apoptotic protein associated with neuronal differentiation in retinal tissue |
|
2000 |
| Modelo para estudos do papel de Myc/Max e da exclusão nuclear durante a apoptose |
|
2000 |
| Modulation of apoptosis in retinal tissue in vitro |
|
1999 |
| Expression and subcellular localization of transcription factors and heat shock proteins in retinal apoptosis |
|
1999 |
| Localização subcelular anômala de proteínas nucleares precede a apoptose |
|
1999 |
| Modulação da apoptose de células proliferantes e diferenciadas da retina |
|
1999 |
| Modelo para estudo do papel de Myc/Max e exclusão nuclear durante a apoptose |
|
1999 |
| Nuclear exclusion of transcription factors in retinal apoptosis |
|
1998 |
| Association of c-Jun, c-Fos, c-Myc and Ref-1 with apoptosis and differentiation in the developing retina |
|
1998 |
| Exclusão nuclear dos fatores de transcrição Max e Myc durante a apoptose neuronal |
|
1998 |
| Association of c-Jun, c-Fos, c-Myc and Ref-1 with apoptosis and differentiation in the developing retina |
|
1998 |
